Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3561513 | 0.77 | GPR35 (0.36) | GPR35PSMB5TDO2 | |
| SCHEMBL3557120 | 0.77 | GPR35 (0.36) | GPR35PSMB5TDO2 | |
| SCHEMBL3558293 | 0.73 | GPR35 (0.36) | GPR35PSMB5 | |
| SCHEMBL13502106 | 0.67 | P2RX7 (0.32) | GPR35 | |
| SCHEMBL146043 | 0.65 | PSMB5 (0.38) | PSMB5TDO2 | |
| SCHEMBL143816 | 0.65 | TDO2 (0.39) | PSMB5TDO2 | |
| SCHEMBL31240954 | 0.64 | HTR2C (0.52) | PSMB5 | |
| SCHEMBL4580554 | 0.64 | ALDH1A1 (0.42) | PSMB5TDO2 | |
| SCHEMBL28849763 | 0.64 | ALDH1A1 (0.42) | PSMB5TDO2 | |
| SCHEMBL9167795 | 0.63 | PSMB5 (0.46) | PSMB5TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7663301-B2 | for use as robust red organic phosphors | GENERAL ELECTRIC COMPANY (US) | 2010-02-16 | — | — | US | disclosed |
| WO-2006076247-A2 | PHOSPHORESCENT FLUORENE, ANTHRACENE AND/OR THIOPHENE SUBSTITUTED METALLO- PORPHYRINS AND RELATED COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2006-07-20 | — | — | WO | disclosed |
| US-20060152149-A1 | Porphyrin compositions | GENERAL ELECTRIC COMPANY (US) | 2006-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060152149-A1 | Porphyrin compositions | ACP1, MMS19, MVD | GPR35 3198/4885PSMB5 3272/4885TDO2 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.